Monday, 21 January, 2019

Comparable Company Analysis: Wells Fargo & Company (WFC), Lincoln National Corporation (LNC)

Comparable Company Analysis: Wells Fargo & Company (WFC), Lincoln National Corporation (LNC) Comparable Company Analysis: Wells Fargo & Company (WFC), Lincoln National Corporation (LNC)
Nellie Chapman | 20 January, 2018, 05:42

Hedge funds have recently made changes to their positions in the company. Wells Fargo & Company (NYSE:WFC)'s short interest is 33.99 million shares, or 0.76% of the float.

Research analysts at Oppenheimer boosted their FY2017 earnings per share estimates for shares of Wells Fargo & Co in a research note issued to investors on Tuesday, according to Zacks Investment Research.

On 11/30/2017 John R Shrewsberry, Insider, sold 70,000 with an average share price of $56.90 per share and the total transaction amounting to $3,983,000.00. Jackson Grant Investment Advisers Inc. lifted its position in Wells Fargo & Co by 0.5% during the second quarter. The stock spiked 6.42% last month and is up 4.04 this year. CKW Financial Group's holdings in Wells Fargo & Company were worth $148,000 as of its most recent filing with the SEC. Bremer Natl Association holds 0.7% in Wells Fargo & Company (NYSE:WFC) or 45,356 shares. Brandywine Trust Co, a Delaware-based fund reported 304,853 shares.#img1#. The company maintains price to book ratio of 1.46 industry average at 2.15. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. On Friday, April 15 the stock rating was downgraded by Piper Jaffray to "Underweight". The disclosure for this sale can be found here. Milestone Group Inc sold 11,415 shares as the company's stock declined 8.66% while stock markets rallied. Institutional investors own 75.70% of the company's stock. Schulhoff & Incorporated has invested 0.17% of its portfolio in Wells Fargo & Company (NYSE:WFC). The company's market cap is $311.81 Billion, and the average volume is $18.76 Million. Wells Fargo stock deflated in 2017 on a fake-account scandal but is now trading near all-time highs. Ny State Teachers Retirement invested 1.04% of its portfolio in Wells Fargo & Company (NYSE:WFC). Alta Management Lc stated it has 3.17% in Wells Fargo & Company (NYSE:WFC). The institutional investor held 39,922 shares of the major banks company at the end of 2017Q3, valued at $2.20 million, up from 29,231 at the end of the previous reported quarter. The business had revenue of $22.05 billion for the quarter, compared to analyst estimates of $22.64 billion. Wells Fargo & Company had a net margin of 23.30% and a return on equity of 12.60%.

There were also signs that the JPMorgan's trading businesses have passed the most fallow conditions seen over the last few quarters. The company's revenue for the quarter was down 1.8% on a year-over-year basis. analysts predict that Wells Fargo & Co will post 3.98 earnings per share for the current fiscal year.

A number of brokerages have weighed in on WFC. Bartlett & Company Ltd holds 1.59% of its portfolio in Wells Fargo & Company (NYSE:WFC) for 688,618 shares.

ATR value of the company was 0.44 and Relative Strength Index (RSI) was 71.55. Shares in Wells Fargo fell 0.8% in Friday, while the broader stock market recorded gains.

When we look at the Analyst Recommendations of the stock, the company has 1.59 rating given by Analysts where 1 stands for Strong Buy and 5 stands for Strong Sell. Wells Fargo & Co now has a consensus rating of "Hold" and an average target price of $61.02. If you are accessing this article on another domain, it was stolen and republished in violation of USA & global copyright law. Asset and wealth management revenue increased 9% to $3.4 billion. In November, Wells Fargo introduced a feature called Overdraft Rewind, which waives overdraft fees in situations where the bank receives a direct deposit that is large enough to cover the transaction by the following morning. The Company's Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.